OTUD5 promotes end-joining of deprotected telomeres by promoting ATM-dependent phosphorylation of KAP1


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
17 Oct 2024
Historique:
received: 15 12 2023
accepted: 08 10 2024
medline: 18 10 2024
pubmed: 18 10 2024
entrez: 17 10 2024
Statut: epublish

Résumé

Appropriate repair of damaged DNA and the suppression of DNA damage responses at telomeres are essential to preserve genome stability. DNA damage response (DDR) signaling consists of cascades of kinase-driven phosphorylation events, fine-tuned by proteolytic and regulatory ubiquitination. It is not fully understood how crosstalk between these two major classes of post-translational modifications impact DNA repair at deprotected telomeres. Hence, we performed a functional genetic screen to search for ubiquitin system factors that promote KAP1

Identifiants

pubmed: 39420004
doi: 10.1038/s41467-024-53404-0
pii: 10.1038/s41467-024-53404-0
doi:

Substances chimiques

Tripartite Motif-Containing Protein 28 EC 2.3.2.27
Ataxia Telangiectasia Mutated Proteins EC 2.7.11.1
TRIM28 protein, human EC 2.3.2.27
OTUD5 protein, human EC 3.4.-
ATM protein, human EC 2.7.11.1
Ubiquitin-Protein Ligases EC 2.3.2.27
Heterochromatin 0
Endopeptidases EC 3.4.-

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

8960

Subventions

Organisme : EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 Marie Skłodowska-Curie Actions (H2020 Excellent Science - Marie Skłodowska-Curie Actions)
ID : 812829
Organisme : KWF Kankerbestrijding (Dutch Cancer Society)
ID : 2019-2/12826
Organisme : KWF Kankerbestrijding (Dutch Cancer Society)
ID : institutional grant to the Netherlands Cancer Institute
Organisme : Dutch Ministry of Health, Welfare and Sport | Rijksinstituut voor Volksgezondheid en Milieu (Netherlands National Institute for Public Health and the Environment)
ID : Institutional grant to the Netherlands Cancer Institute

Informations de copyright

© 2024. The Author(s).

Références

Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646–674 (2011).
doi: 10.1016/j.cell.2011.02.013
Maciejowski, J. & de Lange, T. Telomeres in cancer: tumour suppression and genome instability. Nat. Rev. Mol. Cell Biol. 18, 175–186 (2017).
pmcid: 5589191 doi: 10.1038/nrm.2016.171
Shay, J. W. & Wright, W. E. Hayflick, his limit, and cellular ageing. Nat. Rev. Mol. Cell Biol. 1, 72–76 (2000).
doi: 10.1038/35036093
Karlseder, J., Smogorzewska, A. & de Lange, T. Senescence induced by altered telomere state, not telomere loss. Science 295, 2446–2449 (2002).
doi: 10.1126/science.1069523
Denchi, E. L. & de Lange, T. Protection of telomeres through independent control of ATM and ATR by TRF2 and POT1. Nature 448, 1068–1071 (2007).
doi: 10.1038/nature06065
Bae, N. S. & Baumann, P. A RAP1/TRF2 complex inhibits nonhomologous end-joining at human telomeric DNA ends. Mol. Cell 26, 323–334 (2007).
doi: 10.1016/j.molcel.2007.03.023
Lazzerini-Denchi, E. & Sfeir, A. Stop pulling my strings - what telomeres taught us about the DNA damage response. Nat. Rev. Mol. Cell Biol. 17, 364–378 (2016).
pmcid: 5385261 doi: 10.1038/nrm.2016.43
van Steensel, B., Smogorzewska, A. & de Lange, T. TRF2 protects human telomeres from end-to-end fusions. Cell 92, 401–413 (1998).
doi: 10.1016/S0092-8674(00)80932-0
Stansel, R. M., de Lange, T. & Griffith, J. D. T-loop assembly in vitro involves binding of TRF2 near the 3’ telomeric overhang. EMBO J. 20, 5532–5540 (2001).
pmcid: 125642 doi: 10.1093/emboj/20.19.5532
Sfeir, A. & de Lange, T. Removal of shelterin reveals the telomere end-protection problem. Science 336, 593–597 (2012).
pmcid: 3477646 doi: 10.1126/science.1218498
Uziel, T. et al. Requirement of the MRN complex for ATM activation by DNA damage. EMBO J. 22, 5612–5621 (2003).
pmcid: 213795 doi: 10.1093/emboj/cdg541
Blackford, A. N. & Jackson, S. P. ATM, ATR, and DNA-PK: the trinity at the heart of the DNA damage response. Mol. Cell 66, 801–817 (2017).
doi: 10.1016/j.molcel.2017.05.015
Banin, S. et al. Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science 281, 1674–1677 (1998).
doi: 10.1126/science.281.5383.1674
Matsuoka, S. et al. Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro. Proc. Natl Acad. Sci. USA 97, 10389–10394 (2000).
pmcid: 27034 doi: 10.1073/pnas.190030497
Burma, S., Chen, B. P., Murphy, M., Kurimasa, A. & Chen, D. J. ATM phosphorylates histone H2AX in response to DNA double-strand breaks. J. Biol. Chem. 276, 42462–42467 (2001).
doi: 10.1074/jbc.C100466200
Ziv, Y. et al. Chromatin relaxation in response to DNA double-strand breaks is modulated by a novel ATM- and KAP-1 dependent pathway. Nat. Cell Biol. 8, 870–876 (2006).
doi: 10.1038/ncb1446
Goodarzi, A. A. et al. ATM signaling facilitates repair of DNA double-strand breaks associated with heterochromatin. Mol. Cell 31, 167–177 (2008).
doi: 10.1016/j.molcel.2008.05.017
Noon, A. T. et al. 53BP1-dependent robust localized KAP-1 phosphorylation is essential for heterochromatic DNA double-strand break repair. Nat. Cell Biol. 12, 177–184 (2010).
doi: 10.1038/ncb2017
Goodarzi, A. A., Kurka, T. & Jeggo, P. A. KAP-1 phosphorylation regulates CHD3 nucleosome remodeling during the DNA double-strand break response. Nat. Struct. Mol. Biol. 18, 831–839 (2011).
doi: 10.1038/nsmb.2077
Schwertman, P., Bekker-Jensen, S. & Mailand, N. Regulation of DNA double-strand break repair by ubiquitin and ubiquitin-like modifiers. Nat. Rev. Mol. Cell Biol. 17, 379–394 (2016).
doi: 10.1038/nrm.2016.58
Mailand, N. et al. RNF8 ubiquitylates histones at DNA double-strand breaks and promotes assembly of repair proteins. Cell 131, 887–900 (2007).
doi: 10.1016/j.cell.2007.09.040
Doil, C. et al. RNF168 binds and amplifies ubiquitin conjugates on damaged chromosomes to allow accumulation of repair proteins. Cell 136, 435–446 (2009).
doi: 10.1016/j.cell.2008.12.041
Poulsen, M., Lukas, C., Lukas, J., Bekker-Jensen, S. & Mailand, N. Human RNF169 is a negative regulator of the ubiquitin-dependent response to DNA double-strand breaks. J. Cell Biol. 197, 189–199 (2012).
pmcid: 3328375 doi: 10.1083/jcb.201109100
Huang, O. W. et al. Phosphorylation-dependent activity of the deubiquitinase DUBA. Nat. Struct. Mol. Biol. 19, 171–175 (2012).
doi: 10.1038/nsmb.2206
de Vivo, A. et al. The OTUD5-UBR5 complex regulates FACT-mediated transcription at damaged chromatin. Nucleic Acids Res. 47, 729–746 (2019).
doi: 10.1093/nar/gky1219
Zhang, T., Cronshaw, J., Kanu, N., Snijders, A. P. & Behrens, A. UBR5-mediated ubiquitination of ATMIN is required for ionizing radiation-induced ATM signaling and function. Proc. Natl Acad. Sci. USA 111, 12091–12096 (2014).
pmcid: 4143036 doi: 10.1073/pnas.1400230111
Konishi, A. & de Lange, T. Cell cycle control of telomere protection and NHEJ revealed by a ts mutation in the DNA-binding domain of TRF2. Genes Dev. 22, 1221–1230 (2008).
pmcid: 2335317 doi: 10.1101/gad.1634008
Sakaue-Sawano, A. & Miyawaki, A. Visualizing spatiotemporal dynamics of multicellular cell-cycle progressions with fucci technology. Cold Spring Harb. Protoc. 2014, https://doi.org/10.1101/pdb.prot080408 (2014).
Boersma, V. et al. MAD2L2 controls DNA repair at telomeres and DNA breaks by inhibiting 5’ end resection. Nature 521, 537–540 (2015).
pmcid: 4481296 doi: 10.1038/nature14216
Li, W. et al. MAGeCK enables robust identification of essential genes from genome-scale CRISPR/Cas9 knockout screens. Genome Biol. 15, 554 (2014).
pmcid: 4290824 doi: 10.1186/s13059-014-0554-4
Yalcin, Z. et al. UBE2D3 facilitates NHEJ by orchestrating ATM signalling through multi-level control of RNF168. Nat. Commun. 15, 5032 (2024).
pmcid: 11169547 doi: 10.1038/s41467-024-49431-6
Enchev, R. I., Schulman, B. A. & Peter, M. Protein neddylation: beyond cullin-RING ligases. Nat. Rev. Mol. Cell Biol. 16, 30–44 (2015).
pmcid: 5131867 doi: 10.1038/nrm3919
Sanjana, N. E., Shalem, O. & Zhang, F. Improved vectors and genome-wide libraries for CRISPR screening. Nat. Methods 11, 783–784 (2014).
pmcid: 4486245 doi: 10.1038/nmeth.3047
Smogorzewska, A., Karlseder, J., Holtgreve-Grez, H., Jauch, A. & de Lange, T. DNA ligase IV-dependent NHEJ of deprotected mammalian telomeres in G1 and G2. Curr. Biol. 12, 1635–1644 (2002).
doi: 10.1016/S0960-9822(02)01179-X
Celli, G. B., Denchi, E. L. & de Lange, T. Ku70 stimulates fusion of dysfunctional telomeres yet protects chromosome ends from homologous recombination. Nat. Cell Biol. 8, 885–890 (2006).
doi: 10.1038/ncb1444
Grolimund, L. et al. A quantitative telomeric chromatin isolation protocol identifies different telomeric states. Nat. Commun. 4, 2848 (2013).
doi: 10.1038/ncomms3848
Ahnesorg, P., Smith, P. & Jackson, S. P. XLF interacts with the XRCC4-DNA ligase IV complex to promote DNA nonhomologous end-joining. Cell 124, 301–313 (2006).
doi: 10.1016/j.cell.2005.12.031
van de Kooij, B., Kruswick, A., van Attikum, H. & Yaffe, M. B. Multi-pathway DNA-repair reporters reveal competition between end-joining, single-strand annealing and homologous recombination at Cas9-induced DNA double-strand breaks. Nat. Commun. 13, 5295 (2022).
pmcid: 9458747 doi: 10.1038/s41467-022-32743-w
Li, F. et al. The deubiquitinase OTUD5 regulates Ku80 stability and non-homologous end joining. Cell Mol. Life Sci. 76, 3861–3873 (2019).
pmcid: 11105630 doi: 10.1007/s00018-019-03094-5
Nishi, R. et al. The deubiquitylating enzyme UCHL3 regulates Ku80 retention at sites of DNA damage. Sci. Rep. 8, 17891 (2018).
pmcid: 6297141 doi: 10.1038/s41598-018-36235-0
Dimitrova, N., Chen, Y. C., Spector, D. L. & de Lange, T. 53BP1 promotes non-homologous end joining of telomeres by increasing chromatin mobility. Nature 456, 524–528 (2008).
pmcid: 2613650 doi: 10.1038/nature07433
Zimmermann, M., Lottersberger, F., Buonomo, S. B., Sfeir, A. & de Lange, T. 53BP1 regulates DSB repair using Rif1 to control 5’ end resection. Science 339, 700–704 (2013).
pmcid: 3664841 doi: 10.1126/science.1231573
Chapman, J. R. et al. RIF1 is essential for 53BP1-dependent nonhomologous end joining and suppression of DNA double-strand break resection. Mol. Cell 49, 858–871 (2013).
pmcid: 3594748 doi: 10.1016/j.molcel.2013.01.002
Di Virgilio, M. et al. Rif1 prevents resection of DNA breaks and promotes immunoglobulin class switching. Science 339, 711–715 (2013).
doi: 10.1126/science.1230624
Escribano-Diaz, C. et al. A cell cycle-dependent regulatory circuit composed of 53BP1-RIF1 and BRCA1-CtIP controls DNA repair pathway choice. Mol. Cell 49, 872–883 (2013).
doi: 10.1016/j.molcel.2013.01.001
Friedman, J. R. et al. KAP-1, a novel corepressor for the highly conserved KRAB repression domain. Genes Dev. 10, 2067–2078 (1996).
doi: 10.1101/gad.10.16.2067
Moosmann, P., Georgiev, O., Le Douarin, B., Bourquin, J. P. & Schaffner, W. Transcriptional repression by RING finger protein TIF1 beta that interacts with the KRAB repressor domain of KOX1. Nucleic Acids Res. 24, 4859–4867 (1996).
pmcid: 146346 doi: 10.1093/nar/24.24.4859
White, D. et al. The ATM substrate KAP1 controls DNA repair in heterochromatin: regulation by HP1 proteins and serine 473/824 phosphorylation. Mol. Cancer Res. 10, 401–414 (2012).
doi: 10.1158/1541-7786.MCR-11-0134
Cubiles, M. D. et al. Epigenetic features of human telomeres. Nucleic Acids Res. 46, 2347–2355 (2018).
pmcid: 5861411 doi: 10.1093/nar/gky006
Garcia-Cao, M., O’Sullivan, R., Peters, A. H., Jenuwein, T. & Blasco, M. A. Epigenetic regulation of telomere length in mammalian cells by the Suv39h1 and Suv39h2 histone methyltransferases. Nat. Genet. 36, 94–99 (2004).
doi: 10.1038/ng1278
Bartocci, C. et al. Isolation of chromatin from dysfunctional telomeres reveals an important role for Ring1b in NHEJ-mediated chromosome fusions. Cell Rep. 7, 1320–1332 (2014).
pmcid: 4054697 doi: 10.1016/j.celrep.2014.04.002
Dejardin, J. & Kingston, R. E. Purification of proteins associated with specific genomic Loci. Cell 136, 175–186 (2009).
pmcid: 3395431 doi: 10.1016/j.cell.2008.11.045
Lin, C. G. et al. The human telomeric proteome during telomere replication. Nucleic Acids Res. 49, 12119–12135 (2021).
pmcid: 8643687 doi: 10.1093/nar/gkab1015
Cho, J. H. et al. Deubiquitinase OTUD5 is a positive regulator of mTORC1 and mTORC2 signaling pathways. Cell Death Differ. 28, 900–914 (2021).
doi: 10.1038/s41418-020-00649-z
Hou, T. et al. Deubiquitinase OTUD5 modulates mTORC1 signaling to promote bladder cancer progression. Cell Death Dis. 13, 778 (2022).
pmcid: 9463452 doi: 10.1038/s41419-022-05128-6
Kim, S. T., Lim, D. S., Canman, C. E. & Kastan, M. B. Substrate specificities and identification of putative substrates of ATM kinase family members. J. Biol. Chem. 274, 37538–37543 (1999).
doi: 10.1074/jbc.274.53.37538
Traven, A. & Heierhorst, J. SQ/TQ cluster domains: concentrated ATM/ATR kinase phosphorylation site regions in DNA-damage-response proteins. Bioessays 27, 397–407 (2005).
doi: 10.1002/bies.20204
Schlam-Babayov, S. et al. Phosphoproteomics reveals novel modes of function and inter-relationships among PIKKs in response to genotoxic stress. EMBO J. 40, e104400 (2021).
doi: 10.15252/embj.2020104400
Vancevska, A., Douglass, K. M., Pfeiffer, V., Manley, S. & Lingner, J. The telomeric DNA damage response occurs in the absence of chromatin decompaction. Genes Dev. 31, 567–577 (2017).
pmcid: 5393052 doi: 10.1101/gad.294082.116
Timashev, L. A., Babcock, H., Zhuang, X. & de Lange, T. The DDR at telomeres lacking intact shelterin does not require substantial chromatin decompaction. Genes Dev. 31, 578–589 (2017).
pmcid: 5393053 doi: 10.1101/gad.294108.116
Kubben, N. et al. Identification of differential protein interactors of lamin A and progerin. Nucleus 1, 513–525 (2010).
pmcid: 3027055 doi: 10.4161/nucl.1.6.13512
Neumann-Staubitz, P., Kitsberg, D., Buxboim, A. & Neumann, H. A method to map the interaction network of the nuclear lamina with genetically encoded photo-crosslinkers in vivo. Front. Chem. 10, 905794 (2022).
pmcid: 9468544 doi: 10.3389/fchem.2022.905794
Crabbe, L., Cesare, A. J., Kasuboski, J. M., Fitzpatrick, J. A. & Karlseder, J. Human telomeres are tethered to the nuclear envelope during postmitotic nuclear assembly. Cell Rep. 2, 1521–1529 (2012).
pmcid: 3694759 doi: 10.1016/j.celrep.2012.11.019
Wood, A. M., Laster, K., Rice, E. L. & Kosak, S. T. A beginning of the end: new insights into the functional organization of telomeres. Nucleus 6, 172–178 (2015).
pmcid: 4615733 doi: 10.1080/19491034.2015.1048407
Gonzalez-Sandoval, A. & Gasser, S. M. On TADs and LADs: spatial control over gene expression. Trends Genet. 32, 485–495 (2016).
doi: 10.1016/j.tig.2016.05.004
Zong, D., Oberdoerffer, P., Batista, P. J. & Nussenzweig, A. RNA: a double-edged sword in genome maintenance. Nat. Rev. Genet. 21, 651–670 (2020).
doi: 10.1038/s41576-020-0263-7
Lottersberger, F., Karssemeijer, R. A., Dimitrova, N. & de Lange, T. 53BP1 and the LINC complex promote microtubule-dependent DSB mobility and DNA repair. Cell 163, 880–893 (2015).
pmcid: 4636737 doi: 10.1016/j.cell.2015.09.057
Hu, M. et al. Expression of KAP1 in epithelial ovarian cancer and its correlation with drug-resistance. Int. J. Clin. Exp. Med. 8, 17308–17320 (2015).
pmcid: 4694223
Cui, Y. et al. High levels of KAP1 expression are associated with aggressive clinical features in ovarian cancer. Int. J. Mol. Sci. 16, 363–377 (2014).
pmcid: 4307251 doi: 10.3390/ijms16010363
Yokoe, T. et al. KAP1 is associated with peritoneal carcinomatosis in gastric cancer. Ann. Surg. Oncol. 17, 821–828 (2010).
doi: 10.1245/s10434-009-0795-8
Peuscher, M. H. & Jacobs, J. J. DNA-damage response and repair activities at uncapped telomeres depend on RNF8. Nat. Cell Biol. 13, 1139–1145 (2011).
doi: 10.1038/ncb2326
Yang, X. et al. A public genome-scale lentiviral expression library of human ORFs. Nat. Methods 8, 659–661 (2011).
pmcid: 3234135 doi: 10.1038/nmeth.1638
de Krijger, I. et al. MAD2L2 dimerization and TRIP13 control shieldin activity in DNA repair. Nat. Commun. 12, 5421 (2021).
pmcid: 8440562 doi: 10.1038/s41467-021-25724-y

Auteurs

Shiu Yeung Lam (SY)

Division of Oncogenomics, The Netherlands Cancer Institute, Amsterdam, The Netherlands.

Ruben van der Lugt (R)

Division of Oncogenomics, The Netherlands Cancer Institute, Amsterdam, The Netherlands.

Aurora Cerutti (A)

Division of Oncogenomics, The Netherlands Cancer Institute, Amsterdam, The Netherlands.

Zeliha Yalçin (Z)

Division of Oncogenomics, The Netherlands Cancer Institute, Amsterdam, The Netherlands.

Alexander M Thouin (AM)

Division of Oncogenomics, The Netherlands Cancer Institute, Amsterdam, The Netherlands.

Marco Simonetta (M)

Division of Oncogenomics, The Netherlands Cancer Institute, Amsterdam, The Netherlands.

Jacqueline J L Jacobs (JJL)

Division of Oncogenomics, The Netherlands Cancer Institute, Amsterdam, The Netherlands. j.jacobs@nki.nl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH